Cerebro

product on market Capsule Syntrax Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains Bacopa monnieri and Rhodiola rosea, which have moderate evidence for supporting cognitive function and stress resilience. Huperzia serrata and Vinpocetine are included for potential neuroprotective effects, though clinical evidence for these specific dosages is limited. The ingredient profile maintains a high safety rating.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Cerebro
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
90
Servings
Other Combinations
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Bacopa monniera leaf extract
100 mg
Market median: 0.15mg (41 products)
Market median: 300.0mg (122 products) 22 studies (A:0, B:7)
Vinpocetine
10 mg

Other Ingredients

Microcrystalline Cellulose Kosher Gelatin Titanium Oxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

RECOMMENDATIONS: As an adult dietary supplement, take 1 capsule two to three times daily with meals.

Warnings & Precautions

Use only under the advice of your physician if you are pregnant or nursing a baby, taking prescription medication or have a medical condition.

Keep out of the reach of children.

Additional Information

Mind Focusing... Intelligence Stimulating... Thought Provoking... Neuro Clarifying... Mental Clarifying... Brain Enhancing...

Neuro Charging

Mental Optimizer

CEREBRO

Metadata

Product Details

DSLD Entry Date2014-06-25
Product TypeOther Combinations
FormCapsule
BrandSyntrax
DSLD ID34766
Data Updated2026-04-11
Research

Research Evidence

2
Research Sources
64
Avg Quality
2
Cochrane Review
B Huperzine A for vascular dementia.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
B Huperzine A for mild cognitive impairment.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
View all evidence for Huperzine A →
Compare

Similar Products

View all Huperzine A products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.